MARKER THERAPEUTICS, INC. Payment for Management Fee
MARKER THERAPEUTICS, INC. (MRKR) reported Payment for Management Fee of -$3.75 thousand for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-08-18.
Discontinued › Notes
us-gaap:PaymentForManagementFee · last filed 2014-08-18
- MARKER THERAPEUTICS, INC. payment for management fee for the quarter ending 2014-06-30 was -$3.75K.
- MARKER THERAPEUTICS, INC. payment for management fee for the quarter ending 2013-06-30 was -$11.93K.
| Period end | Payment for Management Fee 3 month | Payment for Management Fee 6 month | Payment for Management Fee 179 month |
|---|---|---|---|
| 2014-06-30 | -$3.75K 10-Q · filed 2014-08-18 | -$7.50K 10-Q · filed 2014-08-18 | -$4.50M 10-Q · filed 2014-08-18 |
| 2013-06-30 | -$11.93K 10-Q · filed 2014-08-18 | -$27.49K 10-Q · filed 2014-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |